These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2483411)

  • 1. Postimmunization activity of oligoadenylate synthetase in peripheral blood lymphocytes from healthy individuals.
    Bonnevie-Nielsen V; Heron I; Kristensen T; Michelsen B; Lernmark A
    J Clin Lab Immunol; 1989 Apr; 28(4):155-60. PubMed ID: 2483411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines.
    Penn LJ; Williams BR
    J Virol; 1984 Mar; 49(3):748-53. PubMed ID: 6199512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine.
    Bonnevie-Nielsen V; Heron I; Monath TP; Calisher CH
    Clin Diagn Lab Immunol; 1995 May; 2(3):302-6. PubMed ID: 7664176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome.
    Vojdani A; Choppa PC; Lapp CW
    J Clin Lab Immunol; 1998; 50(1):1-16. PubMed ID: 10189612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.
    Vojdani A; Lapp CW
    Immunopharmacol Immunotoxicol; 1999 May; 21(2):175-202. PubMed ID: 10319275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2',5' oligoadenylate synthetase activity in bovine peripheral blood mononuclear cells following bovine herpesvirus type-1-induced respiratory disease: a prognostic indicator?
    Bielefeldt Ohmann H; Campos M; Harland R; Griebel PJ; Babiuk LA
    J Interferon Res; 1989 Apr; 9(2):159-66. PubMed ID: 2715670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine.
    Bonnevie-Nielsen V; Larsen ML; Frifelt JJ; Michelsen B; Lernmark A
    Diabetes; 1989 Dec; 38(12):1636-42. PubMed ID: 2573556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of interferon levels, antiviral state, 2',5'-oligoadenylate synthetase and side effects in healthy men.
    Barouki FM; Witter FR; Griffin DE; Nadler PI; Woods A; Wood DL; Lietman PS
    J Interferon Res; 1987 Feb; 7(1):29-39. PubMed ID: 3035034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
    Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
    Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cells.
    Handgretinger R; Bruchelt G; Kimmig A; Lang P; Daurer B; Dopfer R; Treuner J; Niethammer D
    J Interferon Res; 1990 Feb; 10(1):75-82. PubMed ID: 2109781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases.
    Buffet-Janvresse C; Magard H; Robert N; Hovanessian AG
    Ann Immunol (Paris); 1983; 134D(2):247-58. PubMed ID: 6197930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma.
    Buffet-Janvresse C; Hovanessian AG
    Proc Soc Exp Biol Med; 1984 Feb; 175(2):169-75. PubMed ID: 6198652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
    Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interferon/2-5A synthetase system in primary preleukaemia patients.
    Justesen J; Hokland P; Hokland M
    Prog Clin Biol Res; 1985; 202():439-47. PubMed ID: 3868780
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent elevation of 2-5A synthetase and prognosis in the AIDS-related complex (ARC).
    Read SE; LeBrocq FJ; Williams BR
    Prog Clin Biol Res; 1985; 202():405-13. PubMed ID: 3008172
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon stimulates the expression of 2',5'-oligoadenylate synthetase and MHC class I antigens in insulin-producing cells.
    Bonnevie-Nielsen V; Gerdes AM; Fleckner J; Petersen JS; Michelsen B; Dyrberg T
    J Interferon Res; 1991 Oct; 11(5):255-60. PubMed ID: 1723088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent interferonemia and interferon responses in multiple sclerosis.
    Hertzog PJ; Wright A; Harris G; Linnane AW; Mackay IR
    Clin Immunol Immunopathol; 1991 Jan; 58(1):18-32. PubMed ID: 1701372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.